Ascites in adult patients with cyanotic congenital heart disease

Efrén Martínez-Quintana1, Fayna Rodríguez-González, Leonardo Cabrera-Pérez

  • 1Cardiology Service, Complejo Hospitalario Universitario Insular-Materno Infantil, Las Palmas de Gran Canaria, Spain.

Insights

Cyanotic congenital heart disease can affect the liver, causing abnormalities like hepatomegaly and ascites. Refractory ascites in these patients is linked to periportal fibrosis and sinusoidal dilatation, potentially triggered by heart failure or the Fontan procedure.

Area of Science:

  • Cardiology
  • Hepatology
  • Internal Medicine

Background:

  • Complications of cyanotic congenital heart disease (CCHD) are well-documented, but liver involvement remains poorly understood.
  • Liver dysfunction in CCHD patients can significantly impact patient outcomes and quality of life.

Purpose of the Study:

  • To investigate the clinical, ultrasonographic, and histological liver manifestations in adult patients with CCHD.
  • To identify potential causes and predictors of liver complications, particularly ascites, in this population.

Main Methods:

  • A prospective study of 25 adult CCHD patients (median age 28.7 years, oxygen saturation 83.3%) was conducted.
  • Data collected included clinical history, liver ultrasonography, laboratory tests, New York Heart Association (NYHA) functional class, and liver biopsy in select cases.
  • Ascites was assessed, and in refractory cases, serum-ascites albumin gradient was measured.

Main Results:

  • 50% of patients showed liver abnormalities on ultrasound, including hepatomegaly (30%) and abnormal echogenicity (10%).
  • Ascites was present in 28% of patients, with 10% having refractory ascites.
  • Liver histology in refractory ascites cases revealed periportal fibrosis and sinusoidal dilatation, associated with conditions like heart failure or Fontan procedure.

Conclusions:

  • Liver abnormalities, including ascites, are common in adults with CCHD.
  • Refractory ascites in CCHD patients is associated with periportal fibrosis and sinusoidal dilatation, suggesting a link to chronic venous congestion and hepatic insult.
  • Further research is needed to elucidate the precise mechanisms and develop targeted therapies for liver complications in CCHD.

Related Concept Videos

Ascites01:19

Ascites

DefinitionAscites is the buildup of fluid inside the peritoneal cavity. It occurs when fluid moves out of the vascular system faster than the peritoneal lymphatics can remove it. This fluid shift is most commonly seen in liver cirrhosis but can also appear in several other systemic disorders.EtiologyCirrhosis remains the leading cause of ascites. Other conditions that can contribute include:Heart failureConstrictive pericarditisAbdominal cancersNephrotic syndromeSevere protein–calorie...
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...